Spinning

Nanoscience Instruments Announces the Launch of the Spinbox Electrospinning and Electrospraying System

Retrieved on: 
Saturday, July 10, 2021

PHOENIX, July 9, 2021 /PRNewswire-PRWeb/ --Nanoscience Instruments proudly announces the launch of the Spinbox, an ideal instrument for entry into professional electrospinning systems.

Key Points: 
  • PHOENIX, July 9, 2021 /PRNewswire-PRWeb/ --Nanoscience Instruments proudly announces the launch of the Spinbox, an ideal instrument for entry into professional electrospinning systems.
  • "Spinbox systems can be easily customized to fit the specific needs of each user," explains Francisco J. Chaparro, PhD, Electrospinning Applications Scientist.
  • The Spinbox is a true benchtop electrospinning system , equipped with its own active exhaust system.
  • This unique ventilation system removes harmful solvent vapors from the Spinbox chamber without requiring space under a fume hood.

Staple Street Capital Sells Ironline Compression’s AMS Division to Surepoint Technologies Group

Retrieved on: 
Wednesday, June 2, 2021

Staple Street Capital (Staple Street Capital or SSC), a leading middle-market private equity firm with approximately $800 million of capital under management, is pleased to announce the sale of Ironline Compressions (Ironline) aftermarket services division (the AMS Division) to Surepoint Technologies Group (Surepoint).

Key Points: 
  • Staple Street Capital (Staple Street Capital or SSC), a leading middle-market private equity firm with approximately $800 million of capital under management, is pleased to announce the sale of Ironline Compressions (Ironline) aftermarket services division (the AMS Division) to Surepoint Technologies Group (Surepoint).
  • Staple Street Capital will continue to own Ironlines compression rental business which acquires, sells, and leases a broad range of gas and air compressor packages across Canadas Western Sedimentary Basin.
  • Tim Kelley, CEO of Ironline stated, We want to thank the Staple Street Capital team for their partnership and support over the years.
  • Staple Street Capital made significant investments in the business that have helped us achieve best-in-class standards for customer satisfaction and operational excellence.

Origen Receives Shareholder Approval of its Plan of Arrangement

Retrieved on: 
Thursday, May 13, 2021

b'Vancouver, British Columbia--(Newsfile Corp. - May 13, 2021) - Origen Resources Inc. (CSE: ORGN) (the "Company" or "Origen") is pleased to announce that its previously announced plan of arrangement (the "Arrangement") has been approved by the Company\'s shareholders.

Key Points: 
  • b'Vancouver, British Columbia--(Newsfile Corp. - May 13, 2021) - Origen Resources Inc. (CSE: ORGN) (the "Company" or "Origen") is pleased to announce that its previously announced plan of arrangement (the "Arrangement") has been approved by the Company\'s shareholders.
  • The Arrangement, which involves spinning out Origen\'s Silver Dollar property to Forty Pillars Mining Corp. ("Forty Pillars"), was approved by shareholders of Origen (the "Origen Shareholders") at an annual general and special meeting (the "Origen Meeting") of the Origen Shareholders held Wednesday, May 12, 2021.
  • At the Origen Meeting, a special resolution approving the Arrangement was approved by 99.99% of the votes cast by Origen Shareholders.\n"With the approval of the Forty Pillars spin-out, we have unlocked value for the Company and its shareholders.
  • Origen will retain Forty Pillars Shares as part of the Arrangement which are not transferred to Origen Shareholders.\nAssuming completion of the Arrangement, in order to receive Origen New Shares and Forty Pillars Shares, registered Origen Shareholders must submit their Origen Shares to Origen\'s transfer agent (Olympia Trust Company) with a duly completed letter of transmittal as soon as practicable following the effective date of the Arrangement.

Confluent Medical Announces Strategic Investment in The Electrospinning Company

Retrieved on: 
Tuesday, May 4, 2021

b'Confluent Medical Technologies Inc. (Confluent) announced today a strategic investment in The Electrospinning Company Ltd. (Electrospinning).

Key Points: 
  • b'Confluent Medical Technologies Inc. (Confluent) announced today a strategic investment in The Electrospinning Company Ltd. (Electrospinning).
  • Additionally, the application of the textile to the valve frame will be fully automated, simplifying the manufacturing process.\n\xe2\x80\x9cThe investment in Electrospinning reinforces Confluent\xe2\x80\x99s strategy of Applying Materials Science to MedTech Innovation,\xe2\x80\x9d said Dean Schauer, CEO and President of Confluent Medical.
  • Additional information about Confluent is available at www.confluentmedical.com .\nElectrospinning offers contract services to design, develop and manufacture nanofiber biomaterials for medical devices and regenerative medicine.
  • Additional information about The Electrospinning Company is available at www.electrospinning.co.uk .\nFor information please contact Confluent Medical, https://confluentmedical.com/ .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210504006122/en/\n'

Use of Nanotechnology to Have Strong Impact on Fiber, Yarn, and Thread Mill Businesses | Discover Company Insights for the Fiber, Yarn, and Thread Mills Industry | BizVibe

Retrieved on: 
Tuesday, April 27, 2021

b"NEW YORK, April 27, 2021 /PRNewswire/ -- BizVibe has identified the use of nanotechnology as a major trend for the fiber, yarn, and thread mills industry.

Key Points: 
  • b"NEW YORK, April 27, 2021 /PRNewswire/ -- BizVibe has identified the use of nanotechnology as a major trend for the fiber, yarn, and thread mills industry.
  • This trend is expected to have a strong influence on fiber, yarn, and thread mill companies, especially in North America, Europe, and Asia-Pacific.
  • The fiber, yarn, and thread mills industry group features 700+ company profiles categorized into 30+ product and service categories.
  • Each category contains detailed insights dedicated to helping procurement and sales teams find trusted suppliers and target sales prospects.\nThe fiber, yarn, and thread mill product and service categories include:\n"

IME Medical Electrospinning appoints Sander de Vos as Chief Business Officer

Retrieved on: 
Thursday, April 1, 2021

WAALRE,Netherlands, April 1, 2021 /PRNewswire/ -- IME Medical Electrospinning, a global leader in electrospun medical devices for tissue rebuilding and regenerative medicine as well as implants and drug delivery solutions,today announced that it has further strengthened its management team with the appointment ofSander de Vos as Chief Business Officer (CBO).

Key Points: 
  • WAALRE,Netherlands, April 1, 2021 /PRNewswire/ -- IME Medical Electrospinning, a global leader in electrospun medical devices for tissue rebuilding and regenerative medicine as well as implants and drug delivery solutions,today announced that it has further strengthened its management team with the appointment ofSander de Vos as Chief Business Officer (CBO).
  • He will be responsible for the worldwide roll-out of the company's medical electrospinning strategy, based on IME's ground-breaking MediSpinXL industrial production platform.
  • Judith Heikoop, CEO of IME Medical Electrospinning comments:
    "We at IME are thrilled to welcome Sander to our fast-growing team of professionals.
  • Sander de Vos (46) is an accomplished executive with more than 15 years of leadership experience across healthcare and biotech commercial and business development positions.

IME Medical Electrospinning appoints Sander de Vos as Chief Business Officer

Retrieved on: 
Thursday, April 1, 2021

WAALRE,Netherlands, April 1, 2021 /PRNewswire/ -- IME Medical Electrospinning, a global leader in electrospun medical devices for tissue rebuilding and regenerative medicine as well as implants and drug delivery solutions,today announced that it has further strengthened its management team with the appointment ofSander de Vos as Chief Business Officer (CBO).

Key Points: 
  • WAALRE,Netherlands, April 1, 2021 /PRNewswire/ -- IME Medical Electrospinning, a global leader in electrospun medical devices for tissue rebuilding and regenerative medicine as well as implants and drug delivery solutions,today announced that it has further strengthened its management team with the appointment ofSander de Vos as Chief Business Officer (CBO).
  • He will be responsible for the worldwide roll-out of the company's medical electrospinning strategy, based on IME's ground-breaking MediSpinXL industrial production platform.
  • Judith Heikoop, CEO of IME Medical Electrospinning comments:
    "We at IME are thrilled to welcome Sander to our fast-growing team of professionals.
  • Sander de Vos (46) is an accomplished executive with more than 15 years of leadership experience across healthcare and biotech commercial and business development positions.

World Outlook for Spinning Machines Industry to 2027, Featuring Itema, Marzoli Spinning Solutions, Murata Machinery, Savio Macchine Tessili and More

Retrieved on: 
Monday, March 15, 2021

DUBLIN, March 15, 2021 /PRNewswire/ -- The "Spinning Machines - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 15, 2021 /PRNewswire/ -- The "Spinning Machines - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Ring Spinning, one of the segments analyzed in the report, is projected to record a 5.6% CAGR and reach US$ 3.1 Billion by the end of the analysis period.
  • The Spinning Machines market in the U.S. is estimated at US$ 1.4 Billion in the year 2020.
  • In the global Other Types segment, USA, Canada, Japan, China and Europe will drive the 4.4% CAGR estimated for this segment.

Peloton Files Meritless Trademark Cancellation Action Against Mad Dogg Athletics’ Incontestable Spinning® and Spin® Trademark Registrations

Retrieved on: 
Tuesday, February 23, 2021

It appears to be little more than retaliation for Mad Dogg Athletics patent infringement lawsuit filed against Peloton in December 2020 seeking relief for Pelotons misuse of Mad Dogg Athletics patented technology.

Key Points: 
  • It appears to be little more than retaliation for Mad Dogg Athletics patent infringement lawsuit filed against Peloton in December 2020 seeking relief for Pelotons misuse of Mad Dogg Athletics patented technology.
  • It is a matter of public record that Mad Dogg Athletics has been continuously using, licensing, and enforcing rights in its SPIN and SPINNING marks for over 25 years, marks closely associated with Mad Dogg Athletics and properly protected by incontestable federal trademark registrations.
  • The company holds numerous Spin and Spinning trademark registrations that have become incontestable under federal trademark law.
  • Weeks before Peloton filed its trademark invalidity petition, Mad Dogg Athletics filed a federal lawsuit against Peloton for patent infringement.

IME Medical Electrospinning and STENTiT enter into development cooperation on resorbable endovascular support grafts to regenerate vascular tissue

Retrieved on: 
Wednesday, February 10, 2021

STENTiT is an emerging player in the field of regenerative medical devices, offering a breakthrough solution for cardiovascular interventions developing first-of-its-kind regenerative endovascular blood vessel implants.

Key Points: 
  • STENTiT is an emerging player in the field of regenerative medical devices, offering a breakthrough solution for cardiovascular interventions developing first-of-its-kind regenerative endovascular blood vessel implants.
  • "We are thrilled to join forces with IME Medical Electrospinning to further optimize our fibrillated endovascular implants.
  • IME Medical Electrospinning develops medical devices in close collaboration with an ever-growing portfolio of customers and partners worldwide within the industry, the scientific environment, hospitals and medical institutes.
  • STENTiT is a medical device spin-off company from Dutch Eindhoven University of Technology, focusing on the development of regenerative endovascular implants.